Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs McDonald's Corp (MCD) Price & Performance

Axogen IncTrade
McDonald's CorpTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs McDonald's Corp — how do they compare? Axogen Inc trades at $38.69 (market cap $2.06B), while McDonald's Corp trades at $265.85 (market cap $191.08B). The key difference: McDonald's Corp is far larger — about 92.8× Axogen Inc's market cap, and McDonald's Corp pays a 2.77% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.

AXGNMCD
Market Cap
$2.06B$191.08B
Sector
TechnologyConsumer Cyclical
52-Week High
$46.19$341.06
52-Week Low
$11.28$264.54
Enterprise Value
$1.98B$244.79B
Volume
2,230,036
Dividend Yield
2.77%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.

The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.

McDonald's Corp

McDonald's (MCD) trades at $268.94, down 1.35% on the day, with a bearish technical signal driven by moving averages. The stock shows strong fundamentals, including a 31.62% net income margin and consistent revenue growth, reaching $26.89B in 2025. Recent news highlights the company's 'McDonald's NEXT' strategy focusing on automation and menu innovation to counter competition and inflation pressures.

The outlook remains positive with a consensus price target of $326.36, implying 21% upside, supported by 59.68% analyst buy ratings. Key risks include inflationary cost pressures on franchisee margins and high long-term debt of $38.42B. Earnings momentum is mixed, with a Q2 2026 estimate of $3.33 EPS to watch.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About McDonald's Corp

McDonald's Corporation franchises and operates fast-food restaurants in the global restaurant industry. The Company's restaurants serves a variety of value-priced menu products in countries around the world.

Read more on MCD